LoginRegister
    Dr Abhinay named as new CEO of KIMS HospitalsDr Abhinay named as new CEO of KIMS Hospitals
    Glenmark Pharma gets USFDA nod for generic version of Elidel Cream to treat skin conditionsGlenmark Pharma gets USFDA nod for generic version of Elidel Cream to treat skin conditions
    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCOCracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells...
    Lantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plantLantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plant
    Granules India to sell entire stake in Granules OmniChem to JV AjinomotoGranules India to sell entire stake in Granules OmniChem to JV Ajinomoto
    Medtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take overMedtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take over
    Roche Tecentriq wins European nod for breast cancerRoche Tecentriq wins European nod for breast cancer
    Sterling Biotech case: ED records statement of Ahmed Patels son FaisalSterling Biotech case: ED records statement of Ahmed Patel's son Faisal
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules,...
    USFDA grants orphan drug status to AstraZenecas asthma drug FasenraUSFDA grants orphan drug status to AstraZeneca's asthma drug Fasenra
    Brand-name drug prices rising at slower pace, lower amounts: AP AnalysisBrand-name drug prices rising at slower pace, lower amounts: AP Analysis
    Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sourcesPurdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X